Mummy-Derived Medicinal Extracts Show Antiviral Effects
Lab tests suggest historical treatments may have contained bioactive compounds despite long-standing scientific dismissal.
Updated on Oct. 26, 2026 in Botany
Live Poll
Do you trust that historical medical remedies can provide modern health benefits?
Researchers at Marburg University analyzed 24 historical samples of Mumia vera aegyptiaca, a substance derived from mummies once used in medicine. Lab tests showed the extracts reduced flu-induced damage in canine kidney cells, despite no single compound in the substance providing the same effect.
Why it matters
The findings bridge historical medical practices with modern pharmacology by evaluating whether traditional remedies believed to transfer healing properties from the dead actually possessed bioactive components. This research highlights the complex chemical makeup of materials used for centuries before they were largely dismissed by medical science in the 19th century.
Chemical analysis of the 24 samples identified conifer resins and metabolites associated with Aloe. While the bulk extract inhibited influenza-induced damage in MDCK (Madin-Darby Canine Kidney) cells, no single isolated compound accounted for this observed protective activity.
The players
Marburg University
A German research institution that conducted the chemical and biological analysis of the historical mummy samples.
E. Merck
A long-standing pharmaceutical and chemical company that included the substance in its product catalog as late as 1924.
Paracelsus
A 16th-century physician and alchemist who was a prominent proponent of using Mumia vera for medicinal purposes.
The details
Researchers performed a chemical analysis on museum samples, including mummified body parts, bandages, and skulls. They tested these substance extracts on MDCK cells—a standard line of immortalized canine kidney cells used in virology research to evaluate drug efficacy. The results suggest a synergistic interaction between different plant-derived compounds, as the isolated ingredients tested individually failed to replicate the protective impact found in the complete extract.
Timeline
1300: Historical use of Mumia vera in medicine begins.
1493-1541: Paracelsus actively advocates for the substance's medicinal use.
18th century: Pharmacists across Europe sell Mumia vera.
1814: A medical dictionary officially rejects the curative claims of the substance.
1924: E. Merck lists Mumia vera Aegyptiaca in its pharmaceutical catalog.
The Tech Race
This study re-examines the 1814 medical dictionary dismissal of Mumia vera through modern biological screening. It updates the long-standing scientific rejection of the substance by identifying measurable protective effects in vitro.
These findings are strictly limited to historical and laboratory analysis and offer no clinical application for modern medicine. The research serves as a cautionary study on the chemical complexity of ancient medicinal materials rather than a pathway for new treatment development.
The takeaway
The research demonstrates that historical medical substances often contained complex mixtures that require high-resolution screening to understand. Watch for future studies that use these chemical extraction techniques to identify new bioactive compounds from other discarded historical remedies.
Further reading
Explore the intersection of plant-based compounds and historical remedies in our Botany section.
Source note: This article includes information reported by Discover Magazine.
Live Poll
Do you trust that historical medical remedies can provide modern health benefits?
